Most importantly, using CD11b-DTR transgenic mouse model we demonstrate for the first time that conditional macrophage ablation not only decreased expression of CCL20 and FoxP3 but resulted in a significant inhibition of CRC. The gene discussed is FOXP3; the disease is colorectal carcinoma.